Screener
Pacira BioSciences, Inc. PCRX Interest Income
Interest Income at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.
The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028871
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Total operating expenses | 170,474 | 166,933 |
| Income from operations | 6,902 | 1,990 |
| Other income (expense): | ||
| Interest income | 1,930 | 6,895 |
| Interest expense | (3,699) | (4,580) |
| Other, net | (135) | 4,401 |
| Total other (expense) income, net | (1,904) | 6,716 |
| Income before income taxes | 4,998 | 8,706 |
Item 1. FINANCIAL STATEMENTS (Unaudited)
FAQ
- What is Pacira BioSciences, Inc.'s interest income?
- Pacira BioSciences, Inc. (PCRX) reported interest income of $1.93M in Q1 2026.
- How has Pacira BioSciences, Inc.'s interest income changed year-over-year?
- Pacira BioSciences, Inc.'s interest income decreased by 72.0% year-over-year, from $6.9M to $1.93M.
- What is the long-term trend for Pacira BioSciences, Inc.'s interest income?
- Over 4 years (2021 to 2025), Pacira BioSciences, Inc.'s interest income has grown at a 124.4% compound annual growth rate (CAGR), from $896K to $22.73M.
- What does interest income mean?
- Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.
Ask your AI about Pacira BioSciences, Inc.'s interest income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude